Table: Haba Laboratories Inc - 9-MTH group results
Feb 12 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.99 12.92 19.40
(+8.3 pct) (+12.7 pct) (+8.5 pct)
Operating 1.84 1.51 2.52
(+21.9 pct) (+45.8 pct) (+5.0 pct)
Recurring 1.84 1.50 2.50
(+22.9 pct) (+47.8 pct) (+4.6 pct)
Net 1.21 982 mln 1.69
(+23.5 pct) (+51.7 pct) (+5.8 pct)
EPS 308.44 yen 249.69 yen 429.63 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div NIL NIL
-Q4 div 30.00 yen 30.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T